sb 202190 has been researched along with Astrocytoma in 2 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Astrocytoma: Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamke, M | 1 |
| Herpfer, I | 1 |
| Lieb, K | 1 |
| Wandelt, C | 1 |
| Fiebich, BL | 1 |
| Navarro, L | 1 |
| David, M | 1 |
2 other studies available for sb 202190 and Astrocytoma
| Article | Year |
|---|---|
Substance P induces expression of the corticotropin-releasing factor receptor 1 by activation of the neurokinin-1 receptor.
Topics: Animals; Animals, Newborn; Astrocytes; Astrocytoma; Blotting, Western; Cells, Cultured; Dose-Respons | 2006 |
p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide.
Topics: Astrocytoma; Cell Nucleus; DNA-Binding Proteins; Enzyme Inhibitors; Flavonoids; Gene Expression Regu | 1999 |